Avantra Family Wealth Inc. Trims Stake in Cigna Group $CI

Avantra Family Wealth Inc. lowered its stake in Cigna Group (NYSE:CI) by 5.8% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,399 shares of the health services provider’s stock after selling 86 shares during the quarter. Avantra Family Wealth Inc.’s holdings in Cigna Group were worth $462,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CI. Family Legacy Inc. grew its stake in shares of Cigna Group by 0.5% during the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock valued at $2,138,000 after acquiring an additional 31 shares in the last quarter. Impact Investors Inc grew its stake in shares of Cigna Group by 1.6% during the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock valued at $650,000 after acquiring an additional 31 shares in the last quarter. Mission Wealth Management LP grew its stake in shares of Cigna Group by 1.5% during the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock valued at $691,000 after acquiring an additional 32 shares in the last quarter. Westend Capital Management LLC grew its stake in shares of Cigna Group by 8.1% during the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock valued at $140,000 after acquiring an additional 32 shares in the last quarter. Finally, Financial Network Wealth Advisors LLC grew its stake in shares of Cigna Group by 26.8% during the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock valued at $53,000 after acquiring an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of CI stock opened at $303.30 on Tuesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a one year low of $256.89 and a one year high of $358.88. The company’s 50-day simple moving average is $292.64 and its 200-day simple moving average is $309.56. The stock has a market capitalization of $80.96 billion, a price-to-earnings ratio of 16.56, a PEG ratio of 0.91 and a beta of 0.45.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same quarter last year, the company posted $6.72 earnings per share. Cigna Group’s revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were issued a $1.51 dividend. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider owned 25,648 shares of the company’s stock, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

CI has been the subject of several recent analyst reports. Guggenheim restated a “buy” rating and set a $350.00 target price (down from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a research note on Saturday, September 27th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Wells Fargo & Company reduced their price target on shares of Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 14th. Finally, Barclays increased their price target on shares of Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Two analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $371.81.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.